Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcus Biosciences Inc RCUS

Healthcare Biotechnology
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting

Business Wire May 19, 2021

Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights

Business Wire May 5, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire April 26, 2021

Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2? Program at the AACR 2021 Annual Meeting

Business Wire April 10, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire April 9, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire March 24, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire March 9, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire February 25, 2021

Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Highlights

Business Wire February 24, 2021

Arcus Biosciences to Participate in Upcoming Investor Conferences

Business Wire February 11, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire February 9, 2021

Gilead Sciences to Increase Its Ownership In Arcus Biosciences

Business Wire February 1, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire January 26, 2021

Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer

Business Wire January 15, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire January 12, 2021

Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium

Business Wire January 11, 2021

Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead's SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of Directors

Business Wire January 6, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire December 10, 2020

Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer

Business Wire December 9, 2020

Arcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Business Wire November 18, 2020